Literature DB >> 17690884

The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.

Ivan Tattoli1, Leonardo H Travassos, Leticia A Carneiro, Joao G Magalhaes, Stephen E Girardin.   

Abstract

Toll-like receptors (TLRs) and the nucleotide-binding domain, leucine rich repeat containing family (or Nod-like receptors, NLRs) are two important families of microbial sensors that are membrane-associated and cytosolic molecules, respectively. The Nod proteins Nod1 and Nod2 are two NLR family members that trigger immune defense in response to bacterial peptidoglycan. Nod proteins fight off bacterial infections by stimulating proinflammatory signaling and cytokine networks and by inducing antimicrobial effectors, such as nitric oxide and antimicrobial peptides. Nod1 is also critically implicated in shaping adaptive immune responses towards bacterial-derived constituents. In addition, recent evidence has demonstrated that mutations in Nod1 and Nod2 are associated with a number of human inflammatory disorders, including Crohn's disease, Blau syndrome, early-onset sarcoidosis, and atopic diseases. Together, Nod1 and Nod2 represent central players in the control of immune responses to bacterial infections and inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690884     DOI: 10.1007/s00281-007-0083-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  134 in total

1.  CARD4/NOD1 is not involved in inflammatory bowel disease.

Authors:  H Zouali; S Lesage; F Merlin; J-P Cézard; J-F Colombel; J Belaiche; S Almer; C Tysk; C O'Morain; M Gassull; S Christensen; Y Finkel; R Modigliani; C Gower-Rousseau; J Macry; M Chamaillard; G Thomas; J-P Hugot
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Yoshio Wakatsuki; Ivan J Fuss; Warren Strober
Journal:  Immunity       Date:  2006-08-31       Impact factor: 31.745

3.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

4.  Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel.

Authors:  Mark Tremelling; Laura Hancock; Francesca Bredin; Daniel Sharpstone; Shiela A Bingham; Miles Parkes
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

5.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

6.  Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis.

Authors:  Carlos D Rosé; Trudy M Doyle; Gail McIlvain-Simpson; Jessica E Coffman; James T Rosenbaum; Michael P Davey; Tammy M Martin
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

7.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

10.  NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.

Authors:  Gerben Ferwerda; Stephen E Girardin; Bart-Jan Kullberg; Lionel Le Bourhis; Dirk J de Jong; Dennis M L Langenberg; Reinout van Crevel; Gosse J Adema; Tom H M Ottenhoff; Jos W M Van der Meer; Mihai G Netea
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

View more
  48 in total

1.  A novel pathway for inducible nitric-oxide synthase activation through inflammasomes.

Authors:  Carina L Buzzo; Julia C Campopiano; Liliana M Massis; Silvia L Lage; Alexandra A Cassado; Rafael Leme-Souza; Larissa D Cunha; Momtchilo Russo; Dario S Zamboni; Gustavo P Amarante-Mendes; Karina R Bortoluci
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

3.  Expression, purification, and characterization of recombinant NOD1 (NLRC1): A NLR family member.

Authors:  Nadav Askari; Ricardo G Correa; Dayong Zhai; John C Reed
Journal:  J Biotechnol       Date:  2011-10-28       Impact factor: 3.307

4.  [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].

Authors:  S D Gadola
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

5.  Discovery and characterization of 2-aminobenzimidazole derivatives as selective NOD1 inhibitors.

Authors:  Ricardo G Correa; Pasha M Khan; Nadav Askari; Dayong Zhai; Motti Gerlic; Brock Brown; Gavin Magnuson; Roberto Spreafico; Salvatore Albani; Eduard Sergienko; Paul W Diaz; Gregory P Roth; John C Reed
Journal:  Chem Biol       Date:  2011-07-29

Review 6.  The inflammasomes in health and disease: from genetics to molecular mechanisms of autoinflammation and beyond.

Authors:  Cristina Conforti-Andreoni; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 7.  Melatonin, clock genes and mitochondria in sepsis.

Authors:  Darío Acuña-Castroviejo; Ibtissem Rahim; Carlos Acuña-Fernández; Marisol Fernández-Ortiz; Jorge Solera-Marín; Ramy K A Sayed; María E Díaz-Casado; Iryna Rusanova; Luis C López; Germaine Escames
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 8.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

9.  The expression and function of Nod-like receptors in neutrophils.

Authors:  Anna-Karin Ekman; Lars Olaf Cardell
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

Review 10.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.